MSB 5.33% $1.07 mesoblast limited

Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease, page-143

  1. 681 Posts.
    lightbulb Created with Sketch. 126
    In the last couple of months our family has revisited the what if scenarios when it comes to Covid 19 because some of us are in a very high risk category.

    Now perhaps our family is just the odd ones out but the fact remains that after this announcement my mum a former nurse who has had severe RA for many years made this comment when it comes to her and dad...and MSB's trials

    If that's me or dad in hospital you get in there and you get in touch with this scientist or whoever you have to and you demand we be made part of this companies trial and I don't care how much it costs we will pay it ...because we might be lucky not get the placebo, it might work and as a bonus it might do something for my RA too in the process ...now we were having a it of a laugh but there's some real consideration behind that too. She's a wise woman

    Cheers
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.060(5.33%)
Mkt cap ! $1.216B
Open High Low Value Volume
$1.14 $1.14 $1.07 $5.556M 5.065M

Buyers (Bids)

No. Vol. Price($)
12 193123 $1.06
 

Sellers (Offers)

Price($) Vol. No.
$1.07 300057 2
View Market Depth
Last trade - 16.10pm 05/06/2024 (20 minute delay) ?
Last
$1.07
  Change
-0.060 ( 5.22 %)
Open High Low Volume
$1.13 $1.14 $1.07 1328053
Last updated 15.59pm 05/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.